Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditions. 1999

Y Suzuki, and Y Koyanagi, and Y Tanaka, and T Murakami, and N Misawa, and N Maeda, and T Kimura, and H Shida, and J A Hoxie, and W A O'Brien, and N Yamamoto
Departments of Microbiology and Molecular Virology, School of Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8519, Japan.

Cytokines are potent stimuli for CD4(+)-T-cell differentiation. Among them, interleukin-12 (IL-12) and IL-4 induce naive CD4(+) T cells to become T-helper 1 (Th1) or Th2 cells, respectively. In this study we found that macrophage-tropic human immunodeficiency virus type 1 (HIV-1) strains replicated more efficiently in IL-12-induced Th1-type cultures derived from normal CD4(+) T cells than did T-cell-line-tropic (T-tropic) strains. In contrast, T-tropic strains preferentially infected IL-4-induced Th2-type cultures derived from the same donor CD4(+) T cells. Additional studies using chimeric viruses demonstrated that the V3 region of HIV-1 gp120 was the principal determinant for efficiency of replication. Cell fusion analysis showed that cells expressing envelope protein from a T-tropic strain effectively fused with IL-4-induced Th2-type culture cells. Flow cytometric analysis showed that the level of CCR5 expression was higher on IL-12-induced Th1-type culture cells, whereas CXCR4 was highly expressed on IL-4-induced Th2-type culture cells, although a low level of CXCR4 expression was observed on IL-12-induced Th1-type culture cells. These results indicate that HIV-1 isolates exhibit differences in the ability to infect CD4(+)-T-cell subsets such as Th1 or Th2 cells and that this difference may partly correlate with the expression of particular chemokine receptors on these cells. The findings suggest that immunological conditions are one of the factors responsible for inducing selection of HIV-1 strains.

UI MeSH Term Description Entries
D002459 Cell Fusion Fusion of somatic cells in vitro or in vivo, which results in somatic cell hybridization. Cell Fusions,Fusion, Cell,Fusions, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015847 Interleukin-4 A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells. B-Cell Growth Factor-I,B-Cell Stimulatory Factor-1,Binetrakin,IL-4,Mast Cell Growth Factor-2,B Cell Stimulatory Factor-1,B-Cell Growth Factor-1,B-Cell Proliferating Factor,B-Cell Stimulating Factor-1,B-Cell Stimulatory Factor 1,BCGF-1,BSF-1,IL4,MCGF-2,B Cell Growth Factor 1,B Cell Growth Factor I,B Cell Proliferating Factor,B Cell Stimulating Factor 1,B Cell Stimulatory Factor 1,Interleukin 4,Mast Cell Growth Factor 2
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D018417 Th1 Cells A subset of helper-inducer T-lymphocytes which synthesize and secrete INTERLEUKIN-2; INTERFERON-GAMMA; and INTERLEUKIN-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions. T Helper 1 Cells,TH-1 Cells,Type 1 Helper T Cells,Cell, TH-1,Cell, Th1,Cells, TH-1,Cells, Th1,TH 1 Cells,TH-1 Cell,Th1 Cell
D018418 Th2 Cells A subset of helper-inducer T-lymphocytes which synthesize and secrete the INTERLEUKINS IL-4; IL-5; IL-6; and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses. T Helper 2 Cell,T Helper2 Cell,TH-2 Cell,Th2 Cell,Type-2 Helper T Cell,T Helper 2 Cells,T Helper2 Cells,TH-2 Cells,Type-2 Helper T Cells,Cell, T Helper2,Cell, TH-2,Cell, Th2,Cells, T Helper2,Cells, TH-2,Cells, Th2,TH 2 Cell,TH 2 Cells,Type 2 Helper T Cell,Type 2 Helper T Cells
D018664 Interleukin-12 A heterodimeric cytokine that plays a role in innate and adaptive immune responses. Interleukin-12 is a 70 kDa protein that is composed of covalently linked 40 kDa and 35 kDa subunits. It is produced by DENDRITIC CELLS; MACROPHAGES and a variety of other immune cells and plays a role in the stimulation of INTERFERON-GAMMA production by T-LYMPHOCYTES and NATURAL KILLER CELLS. Edodekin Alfa,IL-12,Natural Killer Cell Stimulatory Factor,Cytotoxic Lymphocyte Maturation Factor,IL 12,IL-12 p70,IL12,Interleukin 12,Interleukin-12 p70,Interleukin 12 p70

Related Publications

Y Suzuki, and Y Koyanagi, and Y Tanaka, and T Murakami, and N Misawa, and N Maeda, and T Kimura, and H Shida, and J A Hoxie, and W A O'Brien, and N Yamamoto
December 2000, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology,
Y Suzuki, and Y Koyanagi, and Y Tanaka, and T Murakami, and N Misawa, and N Maeda, and T Kimura, and H Shida, and J A Hoxie, and W A O'Brien, and N Yamamoto
June 1998, Journal of virology,
Y Suzuki, and Y Koyanagi, and Y Tanaka, and T Murakami, and N Misawa, and N Maeda, and T Kimura, and H Shida, and J A Hoxie, and W A O'Brien, and N Yamamoto
August 2006, Cellular immunology,
Y Suzuki, and Y Koyanagi, and Y Tanaka, and T Murakami, and N Misawa, and N Maeda, and T Kimura, and H Shida, and J A Hoxie, and W A O'Brien, and N Yamamoto
January 1995, European journal of immunology,
Y Suzuki, and Y Koyanagi, and Y Tanaka, and T Murakami, and N Misawa, and N Maeda, and T Kimura, and H Shida, and J A Hoxie, and W A O'Brien, and N Yamamoto
January 1997, Journal of virology,
Y Suzuki, and Y Koyanagi, and Y Tanaka, and T Murakami, and N Misawa, and N Maeda, and T Kimura, and H Shida, and J A Hoxie, and W A O'Brien, and N Yamamoto
November 1992, Journal of virology,
Y Suzuki, and Y Koyanagi, and Y Tanaka, and T Murakami, and N Misawa, and N Maeda, and T Kimura, and H Shida, and J A Hoxie, and W A O'Brien, and N Yamamoto
November 1993, International immunology,
Y Suzuki, and Y Koyanagi, and Y Tanaka, and T Murakami, and N Misawa, and N Maeda, and T Kimura, and H Shida, and J A Hoxie, and W A O'Brien, and N Yamamoto
August 2004, Virology,
Y Suzuki, and Y Koyanagi, and Y Tanaka, and T Murakami, and N Misawa, and N Maeda, and T Kimura, and H Shida, and J A Hoxie, and W A O'Brien, and N Yamamoto
February 1997, Nature biotechnology,
Y Suzuki, and Y Koyanagi, and Y Tanaka, and T Murakami, and N Misawa, and N Maeda, and T Kimura, and H Shida, and J A Hoxie, and W A O'Brien, and N Yamamoto
November 2004, Journal of virology,
Copied contents to your clipboard!